Therapeutic targeting of cellular senescence in diabetic macular edema: preclinical and phase 1 trial results
Most Cited Paper
in Retinal Diseases and Treatments
18 Months Post-Publication
Class of 2026
“Therapeutic targeting of cellular senescence in diabetic macular edema: preclinical and phase 1 trial results”
A research intelligence initiative by Pepkio
pri.pepkio.com/top-papers/retinal-diseases-and-treatments/2026/
Topics
cellular senescence · Diabetic macular edema · Senolytic therapy · phase 1 clinical trial · Retinal pigment epithelium · senescence-associated secretory phenotype · vascular endothelial growth factor · Optical coherence tomography · Central subfield thickness · p16INK4a · p21 · SA-β-galactosidase · dasatinib · quercetin · Anti-VEGF therapy · Diabetic retinopathy · Central subfield thickness · Senolytic therapy
Share
Cite this ranking
Pepkio Research Index (PRI). Topics and Trends in Most Cited Retinal Diseases and Treatments Papers, Class of 2026. https://pri.pepkio.com/top-papers/retinal-diseases-and-treatments/2026. Accessed 2026-07-13. Zheng Su, Tinsley Li, Thematic Shifts in Early-High-Impact Cancer Genomics and Diagnostics Research: A Bibliometric and Semantic Analysis. bioRxiv 2026.07.04.736459; doi: https://doi.org/10.64898/2026.07.04.736459